Prescription Opioid Addiction Treatment Study: Should I Participate?
NIDA Center for the Clinical Trials Network (NIDA CCTN).
This brochure, intended for participants thinking about joining the CTN-0030 (Prescription Opioid Addiction Treatment Study (POATS)) protocol, provides an overview of the project and answers any questions participants might have. The main objective of this trial is to identify effective treatment regimen for sublingual Buprenorphine/Naloxone (BUP/NX) in patients dependent on prescription opioids. The first phase will assess the currently prevailing 1-month detoxification practice. The second phase will compare the effectiveness of standard medical (BUP/NX) management and medical management (BUP/NX) enhanced by intensive individual drug counseling (IDC) in those patients that were not successful in the previous phase. (Brochure, PDF, English)